Across TCGA pan-cancer cohorts, KRTAP10-10 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of KRTAP10-10’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where KRTAP10-10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRTAP10-10 is over-expressed in tumor.
COAD and THCA are the cancer types where KRTAP10-10 tumor–normal differential expression is most reproducible.